PCR Chairman Matt Ellis outlines why PCR exists, how we navigated the pandemic, and why bringing a large range of different partners together to make progress against prostate cancer is a win-win for everybody.

PCR scientist Dr Magali Williamson, Kings College London, talks to host Ben Munro-Davies about why she first became interested in a gene called Plexin B1, which controls how cells move, and how she hopes to use what she's learned about this gene to stop prostate cancer spreading.

PCR scientist Professor Iain McEwan of the University of Aberdeen joins host Ben Munro-Davies for a chat about the androgen receptor, testosterone's gatekeeper, and his work to attack its Achilles' heel, so that hormone therapy can keep working. 

David and Catherine Matheson have prostate cancer. One has it in his body, the other has it in her life. Tune in for a candid discussion on David’s diagnosis, how they chose his treatment, how they’ve continued to live their lives and why scientists sometimes need to be reminded that patients are human beings.

CellCentric's CEO, Dr Will West, chats to host Ben Munro-Davies about the exciting field of epigenetics, clinical trials, the world of biotech and their journey so far from lab to clinic.

"When does a dancer stop?" The legendary Sir Matthew Bourne, hailed as the UK's most popular and successful choreographer, chats to host Ben Munro-Davies about prostate cancer, his regular check-ups, and the world of dance.

Fighting Prostate Cancer takes many forms. But Chris Warwick and Rob Mepham have embarked on a unique challenge - driving a fleet of Austin Maestros across Britain to raise money for Prostate Cancer Research. They explain why this unsurprisingly forgotten car is perfect on the road representation of a disease that impacts millions.